Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Ticagrelor causes false-negative functional tests for heparin-induced thrombocytopenia

Julia J. M. Eekels, Christoph Pachler, Nora Krause, Tina Muhr, Gert Waltl, Andreas Greinacher

Blood (2020) 135 (11): 875–878.

https://doi.org/10.1182/blood.2019003582

Published: 2020

Journal Articles

Pharmacokinetics of Ticagrelor in Infants and Toddlers Aged <24 Months with Sickle Cell Disease

Baba PD Inusa, MD, Adlette Inati, MD, Philip Maes, MD, Jessie Githanga, MBChB, MMed, Miguel R. Abboud, MD, Maurizio Miano, Elena Cela, Videlis Nduba, Mohammad Niazi, Magnus Åstrand, Kevin Persson, Anders Rikard Berggren, MD PhD, Glenn Carlson, MD

Blood (2019) 134 (Supplement_1): 1005.

https://doi.org/10.1182/blood-2019-129855

Published: 2019

Journal Articles

Whole Exome Sequencing in Children with Sickle Cell Anemia Who Developed Ischemic Stroke Prior to 4 Years of Age Reveals a Strong Association with Inherited Dyslipidemias

John N. Brewin, Riley Cook, MD, Alexander E Smith, PhD, Valentine Brousse, MD PhD, Julie Brent, MD, Sanjay Tewari, FRCPath, MBBS, Baba PD Inusa, MD, Stephan Menzel, MD PhD, David C Rees

Blood (2019) 134 (Supplement_1): 3571.

https://doi.org/10.1182/blood-2019-123764

Published: 2019

Journal Articles

Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia

Blood (2019) 134 (Supplement_1): 615.

https://doi.org/10.1182/blood-2019-123355

Published: 2019

Journal Articles

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Muhammad Zain Farooq, MD MBBS, Prasanth Lingamaneni, Muhammad Saad Farooq, MBBS, Aakash Putta, MD MBBS, Sheeba Ba Aqeel, VV Pavan Kedar Mukthinuthalapati, Ankit Mangla, MBBS, MD, Paul Rubinstein, MD

Blood (2019) 134 (Supplement_1): 4963.

https://doi.org/10.1182/blood-2019-129607

Published: 2019

Journal Articles

Does Obesity Influence the Efficacy of P2Y12 Inhibitors in Preventing Strokes? a Systematic Review and Meta-Analysis

Ahmad Abu-Hashyeh, MBBS, Saad Ullah Malik, MD, Jennifer Dotson, DO, Abdul Mughees Rana, MD, Warda Faridi, MD, Mohammad M Alhousani, Emilia Cindy Leigh, MD, Mohamed Suliman, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 4950.

https://doi.org/10.1182/blood-2019-130953

Published: 2019

Journal Articles

The Effects of Antiplatelet Agents on Endocytosis

Harvey G. Roweth, BSc,PhD, Michael Malloy, BS, Jodi A. Forward, BS, Julia Ceglowski, BA, Robert C. Flaumenhaft, MD PhD, Joseph E. Italiano, Jr., BS, PhD, Elisabeth Battinelli, MD PhD

Blood (2019) 134 (Supplement_1): 1058.

https://doi.org/10.1182/blood-2019-131912

Published: 2019

Journal Articles

The Inhibition of Platelets Restore Anti-Tumor Immune Response to Ovarian Cancer and Its Therapeutic Implication

Min Soon Cho, PhD, Omayra Gonzalez-Pagan, MD PhD, Karem Court Pinto, PhD, Anil Sood, MD, Vahid Afshar-Kharghan, MD

Blood (2018) 132 (Supplement 1): 3698.

https://doi.org/10.1182/blood-2018-99-116530

Published: 2018

Journal Articles

Ticagrelor Induced Platelet Dysfunction Can be Assessed Under Shear Conditions and Correction By Platelets Is Influenced By Storage Temperature

Thomas Scorer, MBBS,FRCPath,BSc,MRCP, Umang Sharma, BS, Grantham Peltier, MS, Colby McIntosh, BS, Kristin M Reddoch-Cardenas, PhD, Andrew David Mumford, Andrew P Cap, MD PhD

Blood (2018) 132 (Supplement 1): 526.

https://doi.org/10.1182/blood-2018-99-111428

Published: 2018

Journal Articles

Platelets Promote Activation of the Complement System in Ovarian Cancer

Omayra Gonzalez Pagan, MD, Min Soon Cho, PhD, Vahid Afshar-Kharghan, MD

Blood (2018) 132 (Supplement 1): 4970.

https://doi.org/10.1182/blood-2018-99-116752

Published: 2018

Journal Articles

Pharmacokinetics, Pharmacodynamics and Safety of Ticagrelor in Children with Sickle Cell Disease: Results of a Two-Part Phase 2 Study

Lewis L Hsu, MD PhD, S Sarnaik, S Williams, C Amilon, M Rensfeldt, A Berggren

Blood (2017) 130 (Supplement 1): 2251.

https://doi.org/10.1182/blood.V130.Suppl_1.2251.2251

Published: 2017

Journal Articles

GLS-409, a Synergistic Inhibitor of Both P2Y 1 and P2Y 12 : Efficacy in a Canine Model of Recurrent Coronary Thrombosis and Reversibility of Human Platelet Inhibition

Elena Smolensky Koganov, PhD, Alan D Michelson, MD, Ivan B Yanachkov, PhD, Milka I Yanachkova, PhD, George E Wright, PhD, Karin Przyklenk, PhD, Andrew L Frelinger, III, PhD

Blood (2017) 130 (Supplement 1): 630.

https://doi.org/10.1182/blood.V130.Suppl_1.630.630

Published: 2017

Journal Articles

Role of ADP receptors on platelets in the growth of ovarian cancer

Min Soon Cho, Kyunghee Noh, Monika Haemmerle, Dan Li, Hyun Park, Qianghua Hu, Takeshi Hisamatsu, Takashi Mitamura, Sze Ling Celia Mak, Satya Kunapuli, Qing Ma, Anil K. Sood, Vahid Afshar-Kharghan

Blood (2017) 130 (10): 1235–1242.

https://doi.org/10.1182/blood-2017-02-769893

Published: 2017

Includes: Supplemental data

Journal Articles

Ticagrelor breaks up the tumor-platelet party

Annachiara Mitrugno, Owen J. T. McCarty

Blood (2017) 130 (10): 1177–1178.

https://doi.org/10.1182/blood-2017-07-795898

Published: 2017

Journal Articles

Inverse agonism at the P2Y 12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor

Riyaad Aungraheeta, Alexandra Conibear, Mark Butler, Eamonn Kelly, Sven Nylander, Andrew Mumford, Stuart J. Mundell

Blood (2016) 128 (23): 2717–2728.

https://doi.org/10.1182/blood-2016-03-707844

Published: 2016

Journal Articles

Ticagrelor: agonising over its mechanisms of action

William A. E. Parker, Robert F. Storey

Blood (2016) 128 (23): 2595–2597.

https://doi.org/10.1182/blood-2016-10-743930

Published: 2016

Journal Articles

Ticagrelor Modulates Proliferation in Multiple Myeloma Via P1 and P2 Receptor-Mediated Mechanisms

Elan Meltzer, Aranzazu Mediero, Carl Whatling, Jeffrey S Berger, MD, Bruce Cronstein

Blood (2016) 128 (22): 5694.

https://doi.org/10.1182/blood.V128.22.5694.5694

Published: 2016

Journal Articles

Clopidogrel Treatment Is Associated with a Decrease in Cancer Incidence

Avi Leader, MD, Ravit Zelikson-Saporta, Uri Rozovski, MD, David Pereg, MD, Pia Raanani, MD, Galia Spectre, MDPhD, Michael Lishner, MD, Doron Hermoni, MD

Blood (2015) 126 (23): 1124.

https://doi.org/10.1182/blood.V126.23.1124.1124

Published: 2015

Journal Articles

Structural and functional characterization of a specific antidote for ticagrelor

Andrew Buchanan, Philip Newton, Susanne Pehrsson, Tord Inghardt, Thomas Antonsson, Peder Svensson, Tove Sjögren, Linda Öster, Annika Janefeldt, Ann-Sofie Sandinge, Feenagh Keyes, Mark Austin, Jennifer Spooner, Peter Gennemark, Mark Penney, Garnet Howells, Tristan Vaughan, Sven Nylander

Blood (2015) 125 (22): 3484–3490.

https://doi.org/10.1182/blood-2015-01-622928

Published: 2015

Includes: Supplemental data

Journal Articles

Defibrotide Interaction With Newer Oral Anticoagulant and Antiplatelet Drugs

Jawed Fareed, Ph.D., Michael J Moorman, III, Walter Jeske, Ph.D., Debra Hoppensteadt, Ph.D.

Blood (2013) 122 (21): 4804.

https://doi.org/10.1182/blood.V122.21.4804.4804

Published: 2013

NARROW

Ticagrelor causes false-negative functional tests for heparin-induced thrombocytopenia

Pharmacokinetics of Ticagrelor in Infants and Toddlers Aged <24 Months with Sickle Cell Disease

Whole Exome Sequencing in Children with Sickle Cell Anemia Who Developed Ischemic Stroke Prior to 4 Years of Age Reveals a Strong Association with Inherited Dyslipidemias

Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Does Obesity Influence the Efficacy of P2Y12 Inhibitors in Preventing Strokes? a Systematic Review and Meta-Analysis

The Effects of Antiplatelet Agents on Endocytosis

The Inhibition of Platelets Restore Anti-Tumor Immune Response to Ovarian Cancer and Its Therapeutic Implication

Ticagrelor Induced Platelet Dysfunction Can be Assessed Under Shear Conditions and Correction By Platelets Is Influenced By Storage Temperature

Platelets Promote Activation of the Complement System in Ovarian Cancer

Pharmacokinetics, Pharmacodynamics and Safety of Ticagrelor in Children with Sickle Cell Disease: Results of a Two-Part Phase 2 Study

GLS-409, a Synergistic Inhibitor of Both P2Y 1 and P2Y 12 : Efficacy in a Canine Model of Recurrent Coronary Thrombosis and Reversibility of Human Platelet Inhibition

Role of ADP receptors on platelets in the growth of ovarian cancer

Ticagrelor breaks up the tumor-platelet party

Inverse agonism at the P2Y 12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor

Ticagrelor: agonising over its mechanisms of action

Ticagrelor Modulates Proliferation in Multiple Myeloma Via P1 and P2 Receptor-Mediated Mechanisms

Clopidogrel Treatment Is Associated with a Decrease in Cancer Incidence

Structural and functional characterization of a specific antidote for ticagrelor

Defibrotide Interaction With Newer Oral Anticoagulant and Antiplatelet Drugs

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only